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ABSTRACT
Understanding, screening, and providing resources for quality of life factors and
psychosocial distress have become an important area of focus in cancer care. Negative
consequences of poor quality of life and psychosocial distress have been widely studied in
oncological research. The National Comprehensive Cancer Network, or NCCN, defines
“psychosocial distress” as extending on a continuum, “ranging from common normal feelings of
vulnerability, sadness, and fears to problems that can become disabling, such as depression,
anxiety, panic, social isolation, and existential and spiritual crisis” (“National Comprehensive
Cancer Network,” n.d.). Findings have indicated the significant impact of poor quality of life and
psychosocial distress in the cancer patient population. Elevated levels of psychosocial distress
increases the risk of developing depression, anxiety, immune suppression, and may lead to high
levels of stress. Studies have also revealed associations between increased psychosocial distress
levels, relapse, treatment and healing outcomes, and survival rates (Anderson, Kiecolt-Glaser, &
Glaser, 1994; Spiegel & Nemeroff, 1997). Evidence also shows that heightened psychosocial
distress negatively influences a patient’s capability to adhere to their medical plan and treatment
(Allison et al., 1995; Pirl et al., 2007; Zabora, Brintzenhofeszoc, Curbow, Hooker, & Piantadosi,
2001). Attending to these negative outcomes of psychosocial distress and providing supportive
care is a crucial action of oncology practice today. The American College of Surgeons
Commission on Cancer responded to the imperative of addressing psychosocial needs in cancer
care by mandating national cancer centers for accreditation purposes to screen for psychosocial
distress and provide appropriate referral and resources (Standard 3.2). UF Health Cancer Center
– Orlando Health began psychosocial distress screening on January 1st, 2015 with the utilization
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of the Web-based, HIPPA compliant, and action based Cancer Support Source Program. Patient
data responses collected with the Cancer Support Source Program over the first calendar year of
the implementation of the American College of Surgeons Commission on Cancer standards were
analyzed for this research study.
A sample of 317 patient data responses was included to conduct an exploratory factor
analysis (EFA) on the Cancer Support Source Program test items. Specifically, a Principal
Component Analysis (PCA) with an oblique rotational procedure (Promax) was conducted on the
resulting data set for interpretation. Factorial interpretation was made to ascertain latent
dimensions in the Cancer Support Source Program. A five factor structure model was found with
adequate discriminant and face validity. Factors were grouped by conceptual basis and itemloading composition: Distress, Treatment Management and Decisions, Lifestyle, Relationship,
and Substance Use. These factors were collectively termed the Concern Subscales.
The Distress, Treatment Management and Decisions, and Lifestyle Factors were found to
present the most psychometrically sound and internally consistent model. Further analysis was
conducted to examine the resulting factorial structure model on four cancer location groups:
breast, head and neck, lung, and gynecological cancer. Results displayed that no significant
differences were found between cancer location groups and the five extracted factors. However,
an ad hoc test (Tukey’s HSD) revealed two significant differences between the Lifestyle Factor
and cancer location groups at the p < 0.05 level. The Breast Cancer group’s Lifestyle scores were
higher than the Gynecologic Cancer group, and the Breast Cancer group scores were lower than
the Lung Cancer group.
Additionally, the action scores were summed to examine correlation between the five
extracted Concern Subscales. A high correlation was found, indicating that the action items in
iii

the Cancer Support Source questionnaire correspond with the extracted Concern Subscales and
do not need to undergo dimension reduction. Furthermore, a high correlation was also found with
the extracted Distress Concern Subscale and the existing depression subscale in the Cancer
Support Source Program.
Results indicated that the Cancer Support Source Program could indeed benefit from
dimension reduction to ascertain more parsimonious areas of need presented by the cancer
patient population. The 25 single-items in the Cancer Support Source questionnaire may inhibit
the ability to indicate other concerns that may be expressed by the patient. By identifying the
latent dimensions in this exploratory endeavor, we were able to demonstrate how the Cancer
Support Source questionnaire could be refined to include easily scored Concern subscales to
better identify areas of need for each individual patient that is screened for psychosocial distress.
These findings provide an opportunity to impact patient care, opportunities for referral, and
resources for cancer care in a hospital setting using this psychosocial distress screening
instrument.
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CHAPTER ONE: INTRODUCTION
Quality of life and psychosocial issues have been identified as important areas of need in
cancer care. Research has indicated that the presence of psychosocial distress has significant
negative effects on an individual’s quality of life and emotional, physical, and functional
domains (Adler & Page, 2008; Carlson et al., 2004; & Institute of Medicine [IOM], 2007). The
best ways to address this gap in oncology has been a topic for debate in the last two decades. The
goal of high-quality integrated cancer care and the need for related support services has given
rise to newly implemented accreditation standards and guidelines for oncological care. These
guidelines specify the need to assess, measure, and address quality of life and psychosocial
distress issues to optimize and prioritize patient treatment plans (American College of Surgeons
Commission on Cancer, 2012).
Research exists on a variety of quality of life and psychosocial assessment tools to
examine and measure potential areas for referrals, intervention, risk assessment, and supportive
services for cancer patients (Vodermaier, Linden, & Siu, 2009). Furthermore, investigations of
psychometric properties of these measures display strengths and limitations in their ability to
identify and differentiate individuals at risk and in need of additional services (Buzaglo, Miller,
Gayer, Morris, & Golant, 2013). However, psychometric research is limited on a newly created
Web-based psychosocial distress screening program: the Cancer Support Source Program. An
exploratory factor analysis (EFA) has the potential to extend the development and utility of this
instrument. We will be investigating and addressing the empirical research question of the factor
groupings of test items in the Cancer Support Source Program.
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CHAPTER TWO: LITERATURE REVIEW
General Introduction to Quality of Life
Investigating the nature, conceptualization, and delineation of quality of life in health has
been an empirical topic in research literature. The concept of quality of life encompasses
multiple facets of an individual’s life and becomes particularly relevant when analyzed in the
context of health and, more specifically, a cancer diagnosis. Recently, there has been a
heightened focus on quality of life (QOL) and health, research examining the impact of health
related conditions on well-being in physical, social, cognitive, and emotional domains. Quality of
life in patients with cancer plays a pivotal role in their treatment and management of cancerrelated symptoms: it impacts physical, social, cognitive, and psychological domains. Some
common physical symptoms patients experience are pain, fatigue, nausea, vomiting, and loss of
appetite (Aaronson et al., 1993; Pandey, Dhungana, Twi, Byanju, & Khawas, 2015). Impairment
in social functioning, occupational and financial disruptions, diminishment in cognitive ability,
and psychosocial distress are also QOL indicators. Researchers are particularly cognizant of the
impact QOL can have on a patient during their cancer experience, noting the significant role it
plays on treatment outcomes, survival, and relapse rates. There is emerging evidence that
improved QOL is associated with marginally extended survival rates (Pandey, Dhungana, Twi,
Byanju, & Khawas, 2015). Research has shown quality of life factors play a direct role in how
patients adhere to their treatment plan and make health care decisions. Stage of cancer, cancerrelated symptoms, acceptance, and psychosocial distress are specific ways that the expression of
cancer can impact QOL (Heydarnejad, Hassanpour, & Solati, 2011). Oncologists are also
increasingly becoming more aware of addressing QOL factors in their patients. One study
examined 260 oncologists and 80% agreed that QOL information should be obtained from their
2

patients (Bottomley, 2002). The importance of recognizing QOL in tandem with cancer care has
resulted in the formation and implementation of assessment measures to examine the impact
treatment has on cancer care. Evaluating quality of life and health-related issues can help
improve health care by “bridging boundaries between disciplines and between social, mental,
and medical services” (Centers for Disease Control and Prevention [CDC], 2016). This is also a
testament to the importance of integrative and multidisciplinary care in healthcare institutions.

An Overview of Psychosocial Distress
Assessing and understanding psychosocial distress has become a high priority area of
interest in cancer care and in the empirical oncologic literature. Recently, there has been a
greater emphasis on assessing in the treatment, management of care, and screening of patients
with cancer in hospital settings. While the topic of quality of life encompasses various
psychosocial distress symptoms, the National Comprehensive Cancer Network (NCCN) has
provided its own more specific definition of psychosocial distress. NCCN defines “psychosocial
distress” as extending on a continuum, “ranging from common normal feelings of vulnerability,
sadness, and fears to problems that can become disabling, such as depression, anxiety, panic,
social isolation, and existential and spiritual crisis” (“National Comprehensive Cancer Network,”
n.d.). Furthermore, the NCCN emphasizes how psychosocial distress may impede the patient’s
ability to effectively cope with a cancer diagnosis, physical cancer-related symptoms, and
treatment (Phillips, 2009). The prevalence and presence of psychosocial distress in the cancer
population has received considerable attention in recent years. It has been empirically recognized
as a stable and substantial problem, and findings indicate that approximately 30% to 40% of
cancer patients will endure elevated levels of psychosocial distress during their cancer course
3

(Carlson et al., 2004). One third of cancer survivors will experience persistent cancer-related
fatigue and deteriorating mental health and well-being following a cancer diagnosis (Carlson et
al., 2004; Costanzo, Ryff, Singer, & Burton, 2009; Escalante, Hesketh, & Savarese, 2013).
Consequences of distress can cause disability across multiple life domains. Patients suffering
from cancer and with lower quality of life may be more likely to engage in at-risk behaviors and
less likely to adhere to health protection behaviors that may promote their well-being and reduce
stress. Evidence also shows that heightened psychosocial distress negatively influences a
patient’s capability to adhere to their medical plan and treatment (Allison et al., 1995; Pirl et al.,
2007; Zabora, Brintzenhofeszoc, Curbow, Hooker, & Piantadosi, 2001). Elevated levels of
psychosocial distress also increase the risk of developing depression, anxiety, immune
suppression, and may lead to high levels of stress. Chronic stress, a continuous activation of the
sympathetic nervous system, leads to elevated levels of stress hormones such as norepinephrine,
epinephrine, cortisol, and adrenaline (Moreno-Smith, Lutgendorf, & Sood, 2010).
Investigation of human and mice cells have indicated that elevated levels of
norepinephrine may result in metastasis and angiogenesis (Smith, Lutgendorf, & Sood, 2010).
One study reported that immune response is effected by dopamine levels: “…DA depletion
decreases T-cell responses and promotes tumor growth in mice” (Basu, Dasgupta, &
Chowdhury, 1995). Studies have also revealed associations between increased psychosocial
distress levels, relapse, and survival rates (Spiegel & Nemeroff, 1997). Elevated psychosocial
distress levels are also associated with increased length of hospital stays, re-hospitalization costs,
a patient’s desire for death, and morbidity and mortality rates (Allison et al., 1995; Pirl et al.,
2007). These findings emphasize the importance of assessing stress as it relates to clinical
outcomes in cancer care.
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Furthermore, since there is a continuum of psychosocial distress, many patients with
milder subclinical manifestations may not meet strict diagnostic criteria for a mental illness.
However, these individuals are experiencing valid, tangible, and illness-related bio-psycho-social
symptoms that would benefit from supportive services.

Institute of Medicine Report
Supportive care for patients with cancer is a crucial action of oncology practice today.
This movement is traced back to the transformative report by the Institute of Medicine, Cancer
Care for the Whole Patient: Meeting Psychosocial Health Needs in 2007. This empirically and
medically based report provided recommendations and guidelines for addressing whole person,
integrative, and collaborative care for patients with a cancer diagnosis (Adler & Page, 2008;
Institute of Medicine [IOM], 2007). The Institute of Medicine report addressed psychological
problems associated with cancer and illness, the negative consequences of these unmet needs,
and standard of care recommendations for cancer treatment settings to ensure that the
psychosocial needs of patients with cancer could be met and provided an opportunity for
psychological services: “...good quality health care must attend to patients’ psychosocial
problems and provide services to enable them to better manage their illnesses and underlying
health” (Institute of Medicine [IOM], 2007). Addressing psychosocial issues in cancer care has
played a pivotal role in the advancement of oncology care since the release of this Institute of
Medicine Report. Unfortunately, some physicians misjudge, undervalue, and overlook the
significance of psychosocial distress in their oncological patients (Fallowfield, Ratcliffe, Jenkins,
& Saul, 2001; Keller et al., 2004; Merckaert et al., 2005). Findings indicated that less than 30%
of patient-physician interactions discuss psychosocial concerns and needs (Rodriguez et al, 2010;
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Taylor et al., 2011). Oncologist’s clinical detection of depression has also been studied and
findings have indicated a sensitivity rate of 29% and specificity of 85% (Fallowfield et al.,
2001). The failure to detect and discuss these psychosocial concerns and problems in a patient
suffering from a cancer diagnosis is a lost opportunity to provide them with well-rounded
treatment and the ability to improve their overall quality of life. By thus targeting the “whole
person” with high quality and multidisciplinary care, oncological services can improve treatment
outcomes and potentially increase survival rates.

American College of Surgeons Commission on Cancer Standards
The recognition of psychosocial needs in oncology was further supported by the release
of the American College of Surgeons (ACS), Commission on Cancer Standards 3.2 Psychosocial
Distress Screening and 3.3 Survivorship Care Plan in 2015. The implementation date of these
standards was January 1, 2015, and the imperative to meet that target for accreditation purposes
motivated a new focus on patient-centered cancer care: one contingent on providing
multidisciplinary approaches and comprehensive cancer care. These standards served as a
foundation to effectuate psychosocial distress screening measures and survivorship care plans
(SCPs) in accredited cancer sites (American College of Surgeons Commission on Cancer, 2012).
The Survivorship Care Plan (SCPs) Standards mandated the implementation of a
“…comprehensive care summary and follow-up plan to patients with cancer who are completing
cancer treatment” (American College of Surgeons Commission on Cancer, 2012). The guidelines
also recommended continued monitoring, documentation, and evaluation of the implementation
process. The target behind SCPs are to better transition cancer survivors during their post
treatment lives and to diminish negative outcomes that survivors experience, such as cancer6

related fatigue or psychosocial distress. Areas of needs addressed by SCPs may include relevant
information on their cancer type, treatment, follow-up appointments, access to community
resources, coordination and transition to a primary care provider (PCP), lifestyle changes,
screenings, and prevention (Daudt et al., 2014).
A majority of PCPs see the value and importance of SCPs. Research has indicated that
PCPs felt better prepared in their treatment of cancer survivors, particularly in regard to the
comprehensive nature of SCPs and the improvement of care coordination with specialty
oncologists (Shalom, Hahn, Casillas, & Ganz, 2011). Patient benefits from SCPs have also been
researched, with recent studies finding that patients reported satisfaction in the usability, value,
and knowledge provided in the SCPs (Faul et al., 2012; Sparague et al., 2013).
Despite much evidence and enthusiasm for implementation of the national standards,
there have been some recent questions as to their benefit and efficacy. For example, patients
reported continued confusion with coordination of care even following the implementation of
SCPs (Sparague et al., 2013). Recent research is also finding credible and primary concerns with
implementation of SCPs: increased burden and workload on health care clinics, sustainability
and feasibility issues, and utility for patient care (Faul et al., 2012). Furthermore, emerging
research has found that SCPs are ineffective; one systematic review on SCPs found no
significant or measurable benefits on psychosocial distress and cancer outcomes (Brennan,
Gormally, Butow, Boyle, & Spillane, 2014). One response to the controversial evidence of the
inefficacy of SCPs was a revised template issued by the American Society of Clinical Oncology
(ASCO) Survivorship Care Plan Working Group. The template minimized the “critical
elements” required for SCP implementation and aimed to 1) increase adoption of SCP in clinical
settings and 2) reduce resource load (Mayer, D.K., Birken, S.A., Check, D., & Chen, R.C.,
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2015). However, diminished and questionable efficacy of SCPs on survivorship raises the
empirical question of how successful the implementations of the ACS Commission on Cancer
Standards can be in oncology care.

Psychosocial Distress Screening
The Psychosocial Distress Screening Standard specified and mandated that health
professionals engage in psychosocial screening in cancer settings and, in turn, the opportunity for
psychosocial support, services, and resources following cancer treatment. Supportive care can be
more streamlined to directly address each individual case by screening patients with cancer for a
range of psychological, physical, and social needs in tandem with their cancer treatment. The
guidelines mandated that screening should be offered to the cancer patient at least once during a
medical visit, with the exact timing of said medical consultation to be decided by the facility. If
screening reveals a moderate to severe psychosocial distress, the program must provide
additional investigation into how “psychological, behavioral, and social problems of the patient
may interfere with their ability to participate fully in their health care and manage their illness
and its consequences” (“National Comprehensive Cancer Network,” n.d.). Most importantly,
distress screening is tailored to target patients that are at high risk: those that present high levels
of distress and are at an elevated risk for depression. Common distress screening tools include
the NCCN Distress Thermometer (DT), Patient Health Questionnaire 9, Patient Health
Questionnaire 2, Hospital Anxiety and Depression Scale, Beck Depression Inventory, and Brief
Symptom Inventory (Vodermaier, Linden, & Siu, 2009). Monitoring cancer patient’s distress
throughout their treatment and cancer course allows for higher quality oncology care and the
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opportunity for early intervention for psychosocial related problems. This may entail a referral,
consultation, or opportunity for services.
The utilization of a standardized, validated instrument as a screening tool for cancer
populations can have significant benefits: in the optimization of quality for patient-centered care;
continuity of care; dissemination of information; optimization of treatment planning; identifying
and discriminating risks; reduction of distress and barriers; devising cost-effective benefits; and
providing a platform to address additional needs for services and interventions for the cancer
patient. The optimal screening tool should assess the integrative needs of the patient, so as to
provide a comprehensive assessment of all areas connected to their cancer diagnosis. This
includes information about cancer, treatment, behavioral health changes, coping with financial
situations, emotional consequences of cancer, proactive cancer management, occupational
disruptions, practical problems, and familial/social impacts (“National Comprehensive Cancer
Network,” n.d.).
Since January 1, 2015, UF Health Cancer Center – Orlando Health has implemented
routine and mandated psychosocial distress screening with the CancerSupportSource™ (version
2.0) Program. The first patient visit at the clinics is devoted to the patient’s immediate medical
needs, and on departure the psychological needs (support survey) are scheduled to commence at
or prior to their return appointment. The patient may take the support survey online at home or
onsite. An individualized “My Care Plan” is formulated from their responses and due to the
Cancer Support Source Program’s action-based mission, patients are then provided with
opportunities for a broad range of referral and supportive services (Buzaglo, Miller, Gayer,
Morris, & Golant, 2013). Support groups, counseling, psycho- education, pain-management,
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nutrition, and physical exercise can be addressed at the Cancer Support Community, Integrative
Medicine Department at UF Health Cancer Center – Orlando Health.

Relevant Studies on the CSS Program: Efficacy and Implementation in Community
Settings
The psychometric ability of the Cancer Support Source has been investigated with a
community based sample of 319 cancer survivors. High internal consistency was illustrated with
a Cronbach’s alpha of 0.91. Additionally, test-retest reliability of ICC ≥ 0.75 was found to be
strong. The Cancer Support Source Program has also portrayed good concurrent validity and the
strong ability to differentiate clinically significant groups with the Distress Thermometer (R(2) =
0.35, p < 0.001), the Functional Assessment Scale of Cancer Therapy-General Well-Being Scale
(R(2) = 0.58, p < 0.001), and the Center for Epidemiologic Studies Depression Scale (R(2) =
0.48, p < 0.001) (Miller et al., 2012).
An investigation of cancer survivors in a community-based Cancer Support Community
utilized the Cancer Support Source screening program. The study reported that most patients
experienced the highest level of distress within one year of their cancer diagnosis (p = 0.011) and
had a significant risk for depression (p = 0.007). During this time the highest concern of patients
with elevated levels of distress reported the desire to have discussions about their psychosocial
needs. Patients over a year from their cancer diagnosis had a depression risk of 45% and also
reported moderate to severe distress in areas such as worries about future, finances, and physical
exercise (Buzaglo et al., 2016).
Diverse racial-ethnic groups have also been evaluated utilizing the Cancer Support
Source screening program to examine unmet needs and highest distress levels. Findings
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indicated that Latinos had the most significant levels of distress (p = .004). Areas of greatest
concern centered on treatment decisions and financial worries (Buzaglo et al., 2016).
A previous research study has utilized the Cancer Support Source Program to examine
test items that have the greatest discriminatory power by calculating the item discriminatory
index (IDI) using low (≤ 4, n = 60) and high (≥ 13, n = 59) distress respondents with 251 cancer
survivors at a community-based setting. Results showed that test items related to symptoms of
depression, exhaustion, fears, nervousness, functional problems, worries about the future, and
stressors (employment, academic, familial) had the greatest discriminatory power (IDI ≥ 0.8).
Lowest discriminatory power was found with concerns associated with substance use,
transportation, nutrition, and suicidal ideation (Miller, Mullins, Onukwugha, Golant, & Buzaglo,
2014). The greatest discriminatory power found with the depression subscale is associated with
items related to pain, meaning in life, and treatment decisions (Buzaglo, Miller, Golant,
Longacre, & Kennedy, 2016). Findings such as these display the clinical importance of assessing
areas of need to devote appropriate resources in cancer care for supportive services, referral, pain
management, and assistance with treatment decisions.
Preliminary research has investigated the single, existing depression subscale in the
Cancer Support Source Program. This 4-item subscale is efficacious in screening and
discriminating for depression risk. The depression subscale items ask the test respondent how
concerned they are about feeling sad and/or depressed, feeling nervous or afraid, feeling lonely
or isolated, and feeling too tired to do the things you need or want to do (see Appendix C). The
validation study found a 91% sensitivity in identifying depression risk in community based
samples. Furthermore, rating five or more test items on a Likert scale 2 or greater will correctly
recognize a patient requiring further intervention and assessment for depression (Buzaglo,
11

Miller, Gayer, Morris, & Golant, 2013). Additionally, the Cancer Support Source Program has
been evaluated with the NCCN’S Distress Thermometer as a criterion. The validation study,
using the DT score greater than or equal to 4, found a 91% sensitivity and 49% specificity to
“somewhat to very seriously concerned with 5 or more” other test items.

Previous Multivariate Statistical Analyses on the Cancer Support Source Program
Multivariate regression analyses have previously been performed on Cancer Support
Source Program data. Specifically, procedures have examined descriptive concerns of patient
responses and delved into topics such as ethnic groups with highest distress and an examination
of depressive risk, time since cancer diagnosis, and distress levels.
A previous investigation on the Cancer Support Source Program performed a limited
regression analysis to identify ethnic groups (specifically Non-Hispanic White, African
American, and Latino) with the greatest psychosocial distress levels. The multivariate regression
analysis was adjusted for education, income, and age variables to examine the independent effect
of minority ethnic groups on psychosocial distress, depressive symptomatology test items, and
the chosen action to speak with a health professional to address concerns. Findings indicated the
Latino ethnic group had significantly higher levels of distress when compared to the NonHispanic White group and at a higher risk for depression compared to the Non-Hispanic White
and African American groups. One implication of this study was the expressed need for factorial
statistical analysis: “…future research should investigate factors that impact distress” (Buzaglo,
Miller, Kennedy, Longacre, & Golant, 2016).
An additional research study on the Cancer Support Source Program also utilized a
multivariate regression analysis to identify and delineate unmet psychosocial concerns of
12

patients at varying points of cancer diagnosis. The adjusted regression analysis examined age,
distress levels, specific concerns, and the screening response to speak to a health professional
about their concerns. This study also expressed a desire for future investigative procedures of
factors within the test-items: “…identify factors that predict those at greatest risk for ongoing
and persistent distress” (Buzaglo et al., 2016).
To date, there have been no explorations on subgroupings and subscales of the test items
in the Cancer Support Source Program, such as physical, psychosocial, and practical. The
purpose of this study is to determine whether there are underlying relationships between the test
items in the Cancer Support Source Program, and to thus identify domains of need that can be
the basis of improved care for patients with cancer. Individual test items in the Cancer Support
Source Program are helpful, but there may be an additional benefit to grouping and identifying
patterns of test items to thereby direct and prioritize cancer care.
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CHAPTER THREE: METHODOLOGY
Measure
The Cancer Support Source Program has demonstrated validity and reliability in
psychometric studies. This computer and Web-based program contains 25-items and is timelimited and compliant with The Health Insurance Portability and Accountability Act (HIPPA).
The Cancer Support Source Program is also easily accessible for patients, where they can
complete the survey onsite at their medical visit on a tablet or online at home (Buzaglo, Miller,
Kennedy, Longacre, & Golant, 2016). Test items are formulated on a 5-point Likert scale and
ask respondents to rate their current concern severity level from 1(not at all) to 5(very seriously).
The Cancer Support Source Program test items target multiple needs and symptoms of the
patients, and include: nutrition, transportation, sexual problems, sleep, fatigue, emotional coping,
worries, exercise, body image, mobility, treatment, and finances and their desire for assistance in
a brief, concise, and timely manner (see Appendix C). Furthermore, the Cancer Support Source
Program contains companion items which allow the patient to choose the level of action and
need for services to address their distress: talk to a health professional, receive printed resources,
or other information available as online materials (Vodermaier, Linden, & Siu, 2009).

Participants
Participant data was obtained from an archival data set taken from the Cancer Support
Source Program implemented across the UF Health Cancer Center – Orlando Health clinics by
the Integrative Medicine Department. UF Health Cancer Center – Orlando Health has cemented
itself in excellence: it is in the top five national academic cancer sites, is the largest and most
comprehensive cancer program in Florida, and has Commission on Cancer accreditation.
14

Furthermore, the UF Health Cancer Center – Orlando Health is designated by the state as the
only cancer center of excellence in Central Florida. There have been no investigative procedures
performed on Cancer Support Source data housed at a hospital setting, as the primary and
prevalent usage of the Cancer Support Source Program has been in community and stand-alone
sites.
The research study was exempted by the Institutional Review Board at UF Health Cancer
Center – Orlando Health. An approval letter confirming this exemption can be found in
Appendix A. Additionally, a letter from UCF’s Institutional Review Board can be found in
Appendix B. No identifying PHI was utilized in this research endeavor. The original archival
data set was approximately 1000 patient data entries. The N of 1000 was cleaned for data
analysis and the resulting N was comprised of 719 patient data entries. For the purpose of this
study, the data set was split into two randomized subsamples (Group 1, N = 336; and Group 2, N
= 383), and an analysis of one randomized sample group (Group 1, N = 336) was used in this
exploratory research endeavor. The second randomized sample group (Group 2, N = 383) of the
Cancer Support Source Program patient data entries will be used in a future study (Confirmatory
Factor Analysis). The exploratory analysis (EFA) performed in this research study will be a
template for future procedures and statistical analyses on the test items and patient data responses
from the Cancer Support Source Program. Only completed, online, or onsite distress information
from January 1, 2015 to December 31, 2015 was utilized and analyzed for this research study.
This patient data set included cancer location, patient gender, and responses on the test items in
the Cancer Support Source Program.
Participants completed the distress screening, as this is a standard of clinical care, and a
retrospective study examining archival data. As such, the completion of the distress screening
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would represent the wish of the subject to participate in the best interest of their clinical care, and
this data will be used to improve this care.

Justification of Factorial Techniques
For the purpose of this study, an exploratory factor analysis (EFA) was conducted to
analyze underlying and inter-correlated factor groupings of the test items in the Cancer Support
Source Program. The EFA statistical technique is appropriate due to the investigative nature of
this study: to determine and extract groupings of test items to understand patient areas of need in
cancer care targeted by the Cancer Support Source Program. There are neither prior assumptions
nor expectations on the theoretical latent dimensions and constructs of the test items in the
Cancer Support Source Program. This was an exploratory and heuristic endeavor.
The implementation date of the American College of Surgeons Commission on Cancer
Standards 3.2 at UF Health Cancer Center – Orlando Health utilizing the Cancer Support Source
Program began on January 1, 2015. Therefore, data analysis began with 336 archived patients
over a calendar year: starting on January 1, 2015 to December 31, 2015. Research findings
delineate varying recommendations on sample sizes for an EFA. One guideline advised having at
least a sample size of 300 and another study reported that a suitable sample size is greater than
100 (Hair, Anderson, Tatham, & Black, 1995; Tabachnick & Fidell, 2007). Researchers Comrey
and Lee categorize sample sizes of “…100 as poor, 200 as fair, 300 as good, 500 as very good,
and 1000 or more as excellent…” (Comrey, 1973; Williams, Onsman, & Brown, 2014).
Therefore, it can be argued that the data set utilized for this analysis is large enough to
adequately perform an EFA.
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Sample variable ratio (N:p) recommendations have been evaluated in exploratory factor
analysis research findings and guidelines; with ambiguity concerning what sample variable ratio
is optimal. Ranges of sample variable ratios include: “3:1, 6:1, 10:1, 15:1, or 20:1” (Comrey,
1973; Everitt, 1975; Gorsuch, 1983; Guadagnoli & Velicer, 1988; Pett, Lackey, & Sullivan,
2003; Sapnas & Keller, 2002; Swisher, Beckstead, & Bebeau, 2004; Tabachnick & Fidell, 2007;
Thompson, 2004). One previous research study examined the influence of sample size on a data
set’s ability to produce reliable factor solutions (Costello & Osborne, 2005). Findings indicated
that 70% of sample variable ratio data set of 20:1 produced reliable and statistically meaningful
factor solutions and resulted in less misclassification of factors (Costello & Osborne, 2005). The
sample variable ratio is approximately 13:1. Therefore, the sample variable ratio is justified to be
adequate for the multivariate statistical analysis and enhances the probability of extracting
meaningful and interpretable factor solutions (Stevens, 2002).
The Cancer Support Source Program archival data set contains 25 test items in which an
extraction of factor groupings was made from the sample size of 336. The two randomized
subsamples (Group 1, N = 336; and Group 2, N = 383) were randomized utilizing demographic
variables, a p = .1, and repeated trials to uphold the randomized integrity of the two subsamples.
Cross validation, Eigenvalues, scree plots, and a rotational method procedure was used to extract
a factor structure of the test-items and to reveal test items loading on the same factors of these
two sample groups (see Chapter Four: Results).
Research literature on EFAs promote a variety of approaches to factor extraction; these
include: principle components analysis (PCA), principal axis factoring (PAF), alpha factoring,
maximum likelihood, un-weighted least squares, generalized least squares, image factoring, and
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canonical (Tabachnick & Fidell, 2007; Thompson, 2004). The factors were extracted utilizing
the PCA method.
Findings have indicated disparate opinions on the statistical integrity of utilizing a PCA
for a factor analysis. Some statistical research discusses that conducting a PCA extracts
components and not factors, thereby concluding that it is not a true factor analysis procedure
(Tabachnick & Fidell, 2007). However, many researchers have determined that utilizing a PCA
is synonymous to other factorial extraction statistical techniques and will produce nearly
analogous factor loadings. Our theoretical reasoning behind utilizing a PCA is due to its data
reduction ability and its inclusion of both shared and unique variances (Costello & Osborne,
2005). A PCA analysis also assumes redundancy within variables; hence there is a possibility
that variables are correlated and measuring a similar construct, i.e. areas of need in the Cancer
Support Source Program test items. In this regard, we were able to reduce the variables in our
data set to a more parsimonious number of principal components. Furthermore, a PCA analysis
does not take into account a prior notion of underlying latent variables, which aligns with the
exploratory research question.
Factor extraction was based upon multiple criteria, as it is recommended “no single
criteria should be assumed to determine factor extraction” (Costello & Osborne, 2005).
Therefore, an analysis of both the Scree plot and eigenvalues was made to determine the amount
of factor solutions to retain. The utilization of a Scree Plot with eigenvalues resulted in a visual
representation of the possible number of factor solutions (point of diminished return or elbow).
Research has demonstrated that a Scree Plot is reliable to use on data sets with a sample size of
200 or above. Thereby we can justify that the subsample group (N = 336) exemplified an
adequate sample size to feasibly use a Scree Plot. The “Total Variance Explained” in the SPSS
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output and the natural break of the Scree Plot curve was examined to determine retainable
factors. Statistical recommendations emphasize that only rotated and extracted data are
meaningful for interpretation, thus an evaluation of eigenvalues and variances was made after a
rotational method has been performed. Specifically, this interpretation was made using the SPSS
output Total Variance Explained (see Table 1) (Yong & Pearce, 2013).
Multiple analyses were run to diminish possibly subjectivity of this visual inspection test:
this will allow us to retain factors in a manual fashion and to objectively conclude the numerical
quantity of factors in the data set sample groups (Costello & Osborne, 2005). Data extraction
will be supported by these multiple repeated procedures due to the complex, dynamic nature of
interpreting factorial analyses results. Therefore, multiple approaches to our factor extraction
were utilized to 1) avoid subjectivity in interpretation of results and 2) avoid possible errors or
oversights and 3) justify the quantity of meaningful factors within our data set.
A rotational method was utilized to “…maximize high item loadings and minimize low
item loadings” (Williams, Onsman, & Brown, 2014) to combat the possibility of specific test
items in the Cancer Support Source Program relating to more than one factor grouping
(Williams, Onsman, & Brown, 2014). A factorial rotational method is useful in initial factor and
dimension extraction because it identifies “simple and interpretable factors” (Yaremko, Harari,
Harrison, & Lynn, 1986).
Research findings indicate that oblique and orthogonal rotational methods may produce
nearly identical and conceptually similar results (Costello & Osborne, 2005). However, statistical
literature demonstrates that the selection of a specific rotational method is contingent on the
nature of factors being correlated (oblique rotational method) or uncorrelated (orthogonal
rotational method). Findings recommend to initially employ an oblique rotational method to
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determine the optimal rotational procedure to perform on the data set. A manual entry input of
the hypothesized desired number of factors with an oblique rotational method will result in a
degree of correlation within the data set. Hence, the notion here is to guide researchers in
determining the necessity of performing an orthogonal rotation on the data set (Brown,
2009).This method was employed to analyze the degree of correlation in our data set and to
guide our choice of a specific rotational method. As per recommended by statistical researchers
Tabachnick and Fiddell, an analysis of the degree of correlation within our data set was made.
Correlations around .32 or above were interpreted as merit for the utilization and justification of
an oblique rotational analysis, due to the 10% variance overlap. However, if the data set had not
contained correlational factors, then an orthogonal rotational method in our statistical analysis
would have been pursued for final factorial interpretation (Tabachnick & Fidell, 2007). This
methodology was utilized to enhance the credibility and feasibility of our decision to use the
specific rotational method in this statistical analysis.
Statistical findings were interpreted in a meaningful and theoretical fashion. High factor
loadings were analyzed to adequately identify the strength of relationships within test items to
group test items into factors. Additionally, an identification of low and zero factor loadings with
minimal relationship strength confirmed and justified our factor groupings. A cut-off of .32, twotailed alpha level of 0.1, and the rotated factorial procedure was used to make statistically
meaningful and reliable interpretations of the factor loadings (Tabachnick & Fidell, 2007; Yong
& Pearce, 2013).
There is a definite paucity in the Cancer Support Source Program literature of a
multivariate statistical analysis on the specific test items. The key conceptual basis here is to gain
further knowledge on the nature of the factors within these test items. The statistical results will
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demonstrate 1) grouping test items into specific areas of need utilizing factor extraction, 2)
display specific descriptive findings on factors scores, and 3) will be a basis for improvement in
the Cancer Support Source Program. The findings from this study will also disseminate vital
information on factor groupings within the test items; which will generate future research on
underlying subscales and hence provides a foundation for the confirmatory factor analyses
procedure (CFA). Conducting an EFA on the Cancer Support Source Program test items
provides meaningful and relevant information on psychosocial distress screening results to
differentiate patient areas of need in a more parsimonious and valid fashion. The results of our
multivariate statistical analysis (see Chapter 4: Results) can be the basis to improve the
interpretation of the Cancer Support Program screening results to better prioritize and improve
clinical care by determining areas of need (factors) within the test items.
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CHAPTER FOUR: PROCEDURE
The total data set of 719 was randomly split into two subsamples (Group 1, N = 336; and
Group 2, N = 383). The first sample group was used in this study, while the second sample group
was retained for future research to cross-validate the findings presented here. Univariate outliers
were retained in the data set due to the research interest of assessing respondents with extreme
responses to different items.
The two sample groups were compared to ensure that they were not significantly
different on the available measures and to determine if the random split was successful. Chi
square tests were conducted to determine if any significant differences between the two
randomized sample groups existed in the categorical data. Indeed, no significant differences were
found between the two randomized groups concerning the frequency of gender χ2 (2, N = 719) =
2.65, p =.27, depression risk χ2 (1, N = 719) = 0.00, p =.99, and cancer location χ2 (11, N = 719)
= 10.96, p =.45. Next the ordinal items from the two randomized groups were compared.
Independent samples Mann-Whitney U Tests were conducted on the 25 items from Cancer
Support Source questionnaire for the two randomized sample groups. Results from the individual
Mann Whitney U tests did not find significant differences between groups on any of the 25 items
on the Cancer Support Source questionnaire. Since no evidence for differences between the
groups existed on any categorical or ordinal measure, the randomization was deemed successful.
The subsequent analyses and narrative for this thesis is based on the first sample group. The
second sample group will be utilized in future efforts to cross validate the findings obtained here
with Confirmatory Factor Analysis (CFA) procedures.
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Missing Data
Initially, there were 336 patients in the group one sample data set. This data set was
reviewed for missing data. Patients with three or more item non-responses were eliminated (N =
19). Those with two, or less missing responses (N = 58) were retained in data set and mean
replacement was used for the missing items. Therefore, the final data set used here included 317
patients. The top five most common missing responses were the items: “finding meaning and/or
purpose in life” (n = 12), “managing side effects of treatment” (n = 10), “intimacy, sexuality
and/or fertility” (n = 10), “feeling irritable” (n = 11), and “pain or physical discomfort” (n = 11).

Statistical Methods
All statistical analyses were conducted in SPSS Version 23. Exploratory factor analyses
(EFA) were conducted on the data set as the primary statistical analytical procedures. The
specific EFA chosen was Principal Component Analysis (PCA). Specifically, Tabachnick and
Fidell (2013) recommend using a PCA to discover latent dimensions within a set of variables in a
descriptive manner, as is consistent with the aims of the current study. Two PCA’s were
conducted to ascertain the stability of the results. In the first PCA an oblique rotational procedure
(Promax) was conducted and in the second an orthogonal rotational procedure (Varimax) was
used. The Promax rotation is indicated when the factors are likely to correlate, it is expected that
the factors extracted in this current study would exhibit correlation due to their relation with
distress. Furthermore, Promax rotation is recommended due to its conceptual simplicity,
expedient nature with larger data sets, and its ability to achieve a simple structure. In
comparison, the Varimax rotation is recommended for non-correlation driven factors, offers
simplicity in interpretation, and allows for maximization of the variance of the factor loadings
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(Abdi & Williams, 2010). The factor solutions obtained by the two approaches revealed few
differences in the factor structure and resulting item loadings as determined by the variance
accounted for and the Eigenvalues. Since the factors on the Cancer Support Questionnaire are
expected to correlate, the final factor solution is presented and interpreted with the Promax
rotation.

Results
The appropriateness of the data set for EFA was examined in several ways. Tabachnick
and Fidell (2013) recommend that a minimum value for the KMO index (ranging from 0-1) of
0.6 to conduct an adequate factor analysis. The KMO index for this data set was 0.93, which
indicates the data set is well-suited for factor analytic analysis. Bartlett’s Test of Sphericity was
significant (2 (300) = 3620.54, p < .05), therefore the null hypothesis that the correlation matrix
is an identity matrix was rejected, also indicating that the dimensions of the data set can be
reduced (Appendix E). Additionally, all diagonal items in the anti-image correlation matrix met
the recommended criteria of above 0.5, indicating that all items could be retained for factor
analysis. The extracted factors were evaluated to determine the percentage of variance, e.g.
communalities. The recommended minimum value for communalities (0.30-0.40) was met,
confirming that the data set test items had adequate shared common variance and relation with
extracted factors and could all be retained for subsequent analysis (see Appendix G). Tabachnick
and Fidell (2013) criteria also suggest that an adequate factor model will present with less than
50% of non-redundant residuals with an absolute value greater than 0.5, which is confirmed in
this data set as 33.0% non-redundant residuals were found with absolute values greater than 0.5.
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Extracted Factors
The PCA with Promax rotation produced five extracted factors with Eigenvalues (greater
than 1). The first factor explained 38.17% of the variance, the second factor 5.65% of the
variance, the third factor accounted for 5.52 % of the variance, the fourth factor accounted for
4.66% of the variance, and the fifth factor accounted for 4.21% of the variance. The five
extracted factors accounted for 58.20% of the cumulative variance (see Table 1).
Table 1 Total Variance Explained with Principal Component Analysis with Promax Rotation
with Kaiser Normalization

Initial Eigenvalues
Extraction Sums of Squared Loadings
% of
Cumulative %
% of
Cumulative %
Total
Variance
Total
Variance
1
9.54
38.17
38.17
9.54
38.17
38.17
2
1.41
5.65
43.82
1.41
5.65
43.82
3
1.38
5.52
49.33
1.38
5.52
49.33
4
1.17
4.66
53.99
1.17
4.66
53.99
5
1.05
4.21
58.20
1.05
4.21
58.20
6
.93
3.72
61.92
7
.88
3.51
65.42
8
.79
3.18
68.60
9
.77
3.06
71.66
10
.75
3.00
74.66
11
.66
2.65
77.31
12
.65
2.58
79.89
13
.60
2.39
82.28
14
.55
2.19
84.47
15
.53
2.11
86.58
16
.49
1.97
88.54
17
.45
1.79
90.34
18
.43
1.70
92.04
19
.37
1.46
93.50
20
.35
1.39
94.89
21
.32
1.28
96.17
22
.28
1.11
97.28
23
.26
1.05
98.33
24
.22
.89
99.21
25
.20
.79
100.00
Note. When components are correlated, sums of squared loadings cannot be added to obtain a total variance.

Rotated
Sum of
Squared
Loadings

Component

Total
8.12
6.83
5.75
3.34
1.10

The structure matrix suggested five factors for interpretation (see Table 2). The structure
matrix was the primary matrix utilized for interpretation due to its ability to find correlations
between factors and variables (Beavers et al., 2013; Rietveld & Van Hout, 1993). However, the
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pattern matrix was also consulted to reveal replicability and consistency across factor loadings
within the extracted factors. A visual inspection of the structure matrix indicated high factor
loadings for five factors1: Factor 1 (Distress) 9 items, Factor 2 (Treatment Decisions and
Management) 8 items, Factor 3 (Lifestyle) 5 items, Factor 4 (Relationship) 2 items, and Factor 5
(Substance Use) 1 item.
Table 2 Structure Matrix: Factor loadings and Communalities Based on a Principal Component
Analysis with Promax with Kaiser Normalization Rotation for 25 items from the Cancer Support
Source Questionnaire (N = 317)
Item
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

1

Component
1
.320
.660
.359
.339
.538
.639
.864
.332
.654
.557
.854
.840
.553
.369
.733
.514
.310
.629
.691
.689
.362
.488
.199
.341
.627

2
.550
.311
.283
.633
.320
.657
.443
.558
.482
.601
.473
.556
.754
.442
.418
.485
.188
.411
.734
.588
.473
.647
.166
.707
.595

3
.537
.507
.808
.466
.570
.402
.477
.205
.650
.399
.413
.462
.320
.255
.412
.457
.196
.709
.407
.348
.603
.728
.165
.340
.444

4
.379
.425
.133
.195
.358
.483
.378
.136
.060
.389
.251
.234
.184
.796
.449
.317
.794
.220
.149
.304
.215
.303
.160
.305
.375

The factor labels are based on visual inspection of the highest loading items in a factor.
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5
-.196
.154
.189
.181
.118
.024
.032
.405
.184
-.199
-.028
-.023
.110
-.051
.124
.141
.134
.022
-.017
.127
-.380
-.225
.655
-.087
.030

A visual inspection of the Scree Plot indicated a leveling off (the elbow) of Eigenvalues
after five extracted factors, however visual interpretation of the graph was difficult since the first
extracted factor explained a disproportional amount of the variability in the data set (see Figure
1). Due to the subjective nature of interpreting the Scree Plots, and since factors 2 through 5
explained a significant amount of variance and were theoretically coherent, emphasis was placed
on the structure and pattern matrix in order to determine the appropriate number of extracted
factors.

Figure 1 Scree Plot of Eigenvalues and Component Numbers
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Nature of Factors
Two methods were used to demonstrate adequate discriminant validity for the five
extracted factors. First, the structure matrix was evaluated to extrapolate variables loading
significantly on one factor and to ensure that no significant cross-loadings were occurring (see
Table 2). Second, the component correlation matrix was examined to ensure that factor
correlation did not exceed 0.7 (see Table 3). Sufficient face validity was found indicating that
items loading on the same factor made conceptual sense. For example, items loading in the
Treatment Decisions and Management Factor centered on communicating with your doctor,
transportation, managing side effects of treatment (such as body image), decisions about
treatment, and finding reliable information about treatment.
Table 3 Correlations Among Components with Principal Component Analysis with Promax
Rotation with Kaiser Normalization
Component

1

2

3

2

.59

3

.54

.50

4

.38

.34

.31

5

.09

-.07

-.03

4

-.04

Internal consistency of the extracted factors was examined by conducting a reliability
analysis with Cronbach’s Alpha. The Distress Factor had a Cronbach’s Alpha of 0.89, the
Treatment Management and Decisions Factor had a Cronbach’s Alpha of 0.83, the Lifestyle
Factor had a Cronbach’s Alpha of 0.76 and the Relationship factor had a Cronbach’s Alpha of
0.62. A Cronbach’s Alpha for the Substance Use Factor could not be computed because it was a
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single-item factor. The Cronbach’s Alpha for the first three factors would be classified as
acceptable values for a reliability coefficient (George & Mallery, 2003; Tavakol & Dennick,
2011).
Each factor was treated as a subscale score for each patient by totaling the item scores
and dividing by the number of items (with the exception of the last factor which only had a
single item). These factors were computed into subscales and are collectively called the Concern
Subscales. Table 4 presents the items for each subscale on the Cancer Support Questionnaire.
Table 5 presents the correlations between the 5 subscale scores.
Table 4 Cancer Support Source Item Composition for Five Concern Subscales
Item Number on Cancer Support Source
Questionnaire
Distress
2, 7, 9, 11, 12, 15, 16, 20, 25
Treatment Management and Decisions
1, 4, 6, 8, 10, 13, 19, 24
Lifestyle
3, 5, 18, 21, 22
Relationship
14, 17
Substance Use
23
Note. Cancer Support Source Questionnaire test items can be found in Appendix C.
Scale

Table 5 Pearson Correlations Among Five Concern Subscales of Cancer Support Source
Questionnaire
Distress

Treatment

Treatment

.74**

Lifestyle

.71**

.65**

Relationship

.42**

.43**

Lifestyle

Relationship

.33**

Substance
Use
.23**
.21**
.14*
.17**
Note. **. Correlation is significant at the 0.01 level (2-tailed). *. Correlation is significant at the
0.05 level (2-tailed).
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Comparing Cancer Support Source Questionnaire Subscales by Cancer Location
Patients were assigned to cancer location groups. Patients fell into one of 12 cancer
classifications: breast, blood, lung, head and neck, gynecologic, gastrointestinal, skin, prostate,
liver, brain and spine, pancreatic, and multiple locations. Cancer groups which had an N greater
than 20 were retained to compare Cancer Support Group Questionnaire Concern subscales by
cancer location. These four groups were breast, head and neck, lung, and gynecologic cancer.
Table 6 displays the subscale scores by these 4 cancer locations.
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Table 6 Descriptive Statistics for Cancer Support Source Questionnaire Concern Subscales by
Cancer Location

Cancer
Location
M(SD)

Distress

Factor Subscale
Treatment
Management
and
Decisions

Breast
(N = 116)

2.21
(.96)

2.28
(.90)

2.18
(.92)

1.52
(.92)

1.25
(.84)

Lung
(N =21)

2.56
(.97)

2.66
(.96)

2.74
(.87)

1.38
(.69)

1.71
(1.38)

Head and
Neck
(N = 51)

2.23
(.88)

2.27
(.87)

2.20
(.87)

1.55
(.84)

1.27
(.78)

1.20
(.40)

1.41
(1.08)

Lifestyle

Relationship

Substance
Use

Gynecologic
2.19
2.12
2.11
(N = 45)
(.95)
(.76)
(.91)
Note. Standard deviations appear in parentheses below means.

The scores on the five subscales of the Cancer Support Source Questionnaire for these
four cancer groups were compared with MANOVA. No significant multivariate differences were
found by group, Wilk’s Lambda F(15, 621) = 1.55, p < .08, η2 = .03. Univariate tests of effects
were conducted separately for each subscale by group and revealed that the Lifestyle subscale
score approached significance, F(3) = 2.578, p < .06, η2 = .03. Ad hoc tests were then
conducted to identify where the trends were for the cancer groups to differ. Indeed, Tukey’s
HSD revealed two significant differences at the p < 0.05 level. The Breast Cancer group’s
Lifestyle scores were higher than the Gynecologic Cancer group, and the Breast Cancer group
scores were lower than the Lung Cancer group. Figure 2 presents the Lifestyle scores by group.
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Cancer Location

Breast
Lung
Head and Neck
Gynecologic
0

0.5
1
1.5
2
2.5
3
3.5
Lifestyle Factor Subscale Score (M, SD)

4

Figure 2 Bar graph of lifestyle subscale by cancer locations breast, lung, head and neck, and
gynecologic
Comparing Cancer Support Source Questionnaire Subscale Action Items by Cancer
Location
On the Cancer Support Source Questionnaire there is a column of companion items
corresponding to the concern items asking the patient to choose the level of action they wish to
receive (see Appendix C). These questions are called “Action” items. These companion
questions have the header “Please let us know how we can help you...” The three response
options for each item in this column are: “Have a staff person talk with you,” “Provide you
additional information,” or “No action needed.” Thus for each item identifying a specific
concern of the patient, they can indicate whether they require additional personalized attention
on that topic.
In order to develop a scoring system for the four subscales with two or more action items,
each occurrence of a response indicating no action was required was counted as a “0.” Secondly,
each occurrence of a response indicating wanting more information was counted as a “1.” Lastly,
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each occurrence of a response indicating wanting a staff person to talk with them was counted as
a “2.” These scores were then summed within subscales and represented the “Action” score for
that subscale. The mean and standard deviation of this count by Cancer Location is presented in
Table 7.
Table 7 Mean Action Subscale Scores for Cancer Locations Breast, Lung, Head and Neck, and
Gynecologic

Cancer
Location
M(SD)

Action Scores by Subscale
Treatment
Management
and
Distress
Decisions
Lifestyle

Relationship

Breast
(N = 116)

3.41
(4.30)

3.28
(3.53)

2.04
(2.28)

0.37
(.87)

Lung
(N =21)

5.14
(4.79)

4.86
(3.76)

2.71
(2.59)

0.10
(.30)

Head and
Neck
(N = 51)

2.69
(3.23)

2.65
(3.52)

1.49
(1.87)

0.20
(.53)

Gynecologic
(N = 45)

3.04
(4.24)

2.78
(3.33)

1.89
(2.17)

.11
(.32)

3.34
3.18
1.95
(4.15)
(3.54)
(2.22)
Note. Standard deviations appear in parentheses below means.

0.26
(.69)

Total

Next the four Cancer Support Source Subscale Concern Scores were correlated with
Subscale Action Scores. These are presented in Table 8.
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Table 8 Pearson Correlation between Cancer Support Source Subscale Concern Scores with
Subscale Action Scores

Distress
Action
Score

Treatment
Management
and Decisions
Action Score

Lifestyle
Action
Score

Relationship
Action Score

Distress
Concern
Score

Treatment
Management
and Decisions
Concern Score

Treatment
Management
and Decisions
Action Score

.86**

Lifestyle
Action Score

.77**

.76**

Relationship
Action Score

.41**

.42**

.33**

Distress
Concern Score

.78**

.62**

.59**

.34**

Treatment
Management
and Decisions
Concern Score

.68**

.79**

.61**

.39**

.75**

Lifestyle
Concern Score

.62**

.56**

.73**

.27**

.74**

.66**

Relationship
Concern Score

.28**

.28**

.23**

.80**

.41**

.39**

Lifestyle
Concern
Score

.31**

Note. **. Correlation is significant at the 0.01 level (2-tailed).
The four Subscale Action Scores for each of the Cancer Location groups were contrasted
using separate univariate ANOVAs and no significant differences were obtained.

Comparing Depression Subscale with Distress Concern Subscale
The item loadings on the Distress Concern Subscale were investigated to ascertain if
these items correspond to the 4-items that comprise the existing depression subscale: 7, 11, 15,
and 18(see Appendix C). The Distress Concern Subscale did indeed contain three of the items
that are contained in the depression subscale: 7, 11, and 15. These three items also demonstrated
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the highest item loadings on the Distress Concern Subscale with item loadings .864, .854, and
.744, respectively. A high correlation was found between the depression subscale and the
Distress Concern Subscale, r(315) = .91, p < .01. A one-way ANOVA was conducted for the
four cancer location groups (breast, lung, head and neck, and gynecologic cancer) and the
depression subscale. No significant differences were found, F(3, 229) = 1.48, p = .22.
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CHAPTER 5: DISCUSSION
The EFA (Principal Component Analysis) conducted on the Cancer Support Source
Program test items yielded a five factor structure solution, adequate psychometric properties, and
the promise of clinical utility. Specifically, two EFA’s (one performed with an oblique rotation
and one with an orthogonal rotation) were conducted to replicate the solution across procedures.
Additionally, both the structure and pattern matrix were interpreted for resulting item-loadings to
demonstrate that factor extraction and dimension composition were consistent.
The PCA, conducted with Promax rotational procedure was used as the basis for
interpretation. It yielded five factors with eigenvalues greater than 1 which were retained and
extracted. The five factors were labeled using the highest loading item on that factor as a guide.
Items on each factor were coherent and the interpretation was straightforward indicating good
face validity. These factors were computed into subscales and are termed the Concern subscales.
Each factor was labeled as follows: Distress (Factor 1), Treatment Management and Decisions
(Factor 2), Lifestyle (Factor 3), Relationship (Factor 4), and Substance Use (Factor 5). Due to the
few items loading on the Relationship factor and Substance Use factor (2-item and 1-item
loadings respectively), only the Distress, Treatment Management and Decisions, and Lifestyle
Factors could be evaluated for internal consistency with Cronbach’s Alpha. The internal
reliability of those 3 subscales was found to be good to very good.
A further analysis of the five extracted factors indicated that the first factor, Distress
Factor, accounted for 38.17% of the variance and the greatest number of high item loadings (9item loadings). In comparison, the Treatment Management and Decisions Factor (8-item
loadings) accounted for 5.65% of the variance, the Lifestyle Factor (5-item loadings) accounted
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for 5.52% of the variance, the Relationship Factor (2-item loadings) accounted for 4.66% of the
variance, and the Substance Use Factor (1-item loading) accounted for 4.21% of the variance.
A visual inspection of the Scree Plot was less informative in suggesting the correct
number of factors. The scree plot suggested the data were primarily driven by distress and less
by secondary concerns related to treatment, lifestyle, relationship problems, and substance use.
Nonetheless, the scree plot confirms that the Cancer Support Source Program significantly
captures symptoms and concerns related to distress, which supports the use of the Cancer
Support Source as a psychosocial distress screening instrument in a heterogeneous population of
patients with cancer.
A recent study applied an exploratory factor analysis (EFA) to the 29-item Cancer
Problems in Living Scale (CPILS) with a very large data set of patients with heterogeneous
cancer types (Zhao et al., 2009). These researchers identified a 3, 4, and 5 factor solution from
their EFA. Their 5 factor solution resulted in the following subscales: 1) physical distress; 2)
emotional distress; 3) employment/financial problems; 4) friends and family relations; and 5)
fear of recurrence. Four of their five subscales or factors are similar to what was found in this
study utilizing an EFA on the Cancer Support Source Questionnaire. The exception being that
the researchers found a fear of recurrence factor and our EFA findings found a substance use
factor. It is important to note that the CPILS does not contain Action items to direct the clinician
to provide specific services.

Subscale Findings by Cancer Location
Patients in this sample were divided into groups by the location of their cancer. Four
cancer location groups were sufficiently large to statistically compare to one another. They were
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breast, head and neck, lung, and gynecologic cancer. No significant multivariate differences on
the MANOVA were found between cancer group locations and the five subscales. However,
since the Lifestyle Factor approached significance on the multivariate F test (p = .06), ad hoc
tests were conducted for this subscale by these four cancer locations. Two significant differences
emerged with ad hoc testing. That is, the Breast Cancer group’s Lifestyle scores were higher than
the Gynecologic Cancer group, and lower than the Lung Cancer group. These findings indicate
that further research on the impact of cancer location on lifestyle issues is warranted. We are
hopeful that future studies could replicate these findings and in addition, include more complex
patient variables such as cancer type, stage of cancer, duration, and type of cancer treatment.

Action Subscale Scores
One of the features of the Cancer Support Source Questionnaire that distinguishes it from
other illness impact questionnaires is the companion action items to each specific question of
concern. We developed subscales for the Action items to examine whether there was any utility
in summarizing parallel Action subscales with the factor scores described above. This was
accomplished by simply summing the Action items by subscale. It was found that the resulting
Action subscales were highly correlated with their companion Concern subscales and provided
little additional information for interpretation. Therefore, it is recommended that the action items
be used as they are and not be arranged into subscales. As they stand, the Action items are an
effective way to facilitate discussion and intervention with an individual patient.
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Depression Subscale and Distress Concern Subscale
The extracted Distress Concern Subscale was found to be highly correlated with the
existing 4-item depression subscale. This indicates there is a strong relationship between the
Distress Concern Subscale found in this study and the existing depression subscale in the Cancer
Support Source Program. These findings illustrate the Distress Concern Subscale may indeed
capture symptoms of depression in addition to distress.

Recommendations
The Cancer Support Source Program as it is currently used allows the clinician to drill
down to the very specific service needs of the individual patient. In fact, the 25-items represent
25 different potential services the patient may require. From a psychometric perspective this
approach is referred to as an ideographic approach. The Concern subscales developed here for
the Cancer Support Source Program allows comparison of patient’s needs at a construct level of
analysis. With this nomothetic approach, the patient’s level of distress in these five general areas
of need may be evaluated and contrasted using normative values for different populations. That
is, patients with extreme scores on one or more of the Concern subscales can be compared to
other patients with that type of cancer. As they stand, the single items of concern in the Cancer
Support Source Program are useful, but they may fail to capture the complete meaning that a
subscale can portray; Distress, Treatment Management and Decisions, Lifestyle, and
Relationship factors are complex latent constructs with many facets and implications; a single
item may miss the larger issue at hand. That is, single items may miss the forest for the trees. It is
thereby recommended that the Concern subscales be used to inform clinicians in a heuristic
manner. It is also recommended that the Action items be retained and used as currently indicated.
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The Action items give the Cancer Support Source Questionnaire its unique and distinctive
ideographic quality. Since the Concern subscales correlates highly with the Action items when
they are summed into subscales, nothing is lost, and in fact the utility of the questionnaire is
potentially expanded. This enhancement in clinical utility is also demonstrated with the high
correlation findings between the Distress Concern Subscale and the existing depression subscale.
The development of the Concern subscales produced by an exploratory factor analysis is
easily scored. The item-composition of each of the subscales facilitates and targets parsimonious
areas to discuss with the patient in cancer care. This allows for a greater breadth of information
of potential areas of need to address with the patient and enhances the patient’s ability to
ascertain valuable information and/or resources regarding their cancer care.

Future Directions
An area of improvement for the Cancer Support Source Program could be eliminating the
2 or 3 items with lower loadings on the Distress Factor, and the 1 or 2 items with lower loadings
on the Treatment Management and Decision Factor. This would shorten the questionnaire
without affecting the reliability of those scales. This could also make room for creating and
adding new items for the Relationship and Substance Use subscales. Since the Relationship and
Substance Use factors could not produce internally consistent subscales with only 1 or 2 items,
adding items to those scales will enhance their psychometric potential. Relationship and
Substance Use issues are clinically relevant and important constructs for this population. Adding
items would enhance the reliability of the Relationship and Substance Use subscales and provide
a more robust understanding of these specific areas of need in this clinical population.
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The Substance Use subscale presents challenges for the settings that the Cancer Support
Questionnaire is often used. While this subscale can identify patients that warrant referral for
substance abuse intervention, not all community settings have access to such referrals.
Furthermore, the definition of addiction in these settings requires consideration of individual
disease factors and mortality considerations. Even in hospital settings, Cancer Survivor and
Support services are not generally considered a mental health or addiction treatment service, thus
this information gleaned from this subscale may need to be segregated to protected areas of the
medical record. Nonetheless, whether in a hospital or community setting, the substance use
question is important. Employing the Cancer Support Source Program can suggest additional
screening for substance abuse and referral and/or intervention in as minimally intrusive manner
as possible (Tai, Wu, & Clark, 2012).
It is recommended the Concern subscale findings from this research study be used to help
identify normative clinical cut-offs for the Cancer Support Source Program in future studies. As
of now, cut-off scores for the Cancer Support Source Program are arbitrary and are determined
individually by each site employing this instrument. The means and standard deviations for the
Concern subscales by cancer location group reported in this study may contribute to the
development of clinical cut-off recommendations.
Lastly, the preliminary research presented here demonstrated an extracted factor model
that was internally consistent and had adequate discriminant and face validity. Therefore, future
studies should employ the factors found in this study as a template for further confirmatory
procedures (CFA) which will be conducted in the near future with the second sample described
above.
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Impact of Findings
Assessing distress is a critical aspect of cancer care and many studies have indicated that
well-being and quality of life have a significant impact on survival, treatment, and healing
outcomes (Anderson, Kiecolt-Glaser, & Glaser, 1994). The findings presented here confirm the
heterogeneous impact and prevalence of distress and quality of life factors in the cancer patient
population. This study demonstrates how different distress factors are of primary concern in
patients with various cancer locations. Finally, it contributes to the available tools for
recognizing, screening for, and providing appropriate referral and services for patients with
cancer in the areas of distress, treatment management and decisions, lifestyle, relationship, and
substance use problems.

42

APPENDIX A: ORLANDO HEALTH APPROVAL LETTER CONFIRMING
INSITUTATIONAL REVIEW BOARD EXEMPTION
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APPENDIX B: UCF LETTER CONFIRMING ORLANDO HEALTH INSITUTATIONAL
REVIEW BOARD EXEMPTION
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APPENDIX C: CANCER SUPPORT SOURCE PROGRAM TEST ITEMS
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Today, how concerned are you about...?
(Please circle one option)

(please check all that apply)

1. Eating and nutrition
1

2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously

2. Feeling irritable
1

2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously

3. Moving around (walking, climbing stairs, lifting, etc.)
1

2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously

4. Communicating with your doctor
1

2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously

5. Sleep Problems
1

2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously

6. Changes or disruptions in work, school, or home life
1

Please let us know how we
can help you...

2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously
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□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

7. Feeling sad or depressed
1

2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously

8. Transportation to treatment and appointments
1

2

3

Not at all

Slightly Moderately

4

5

2

3

Not at all

Slightly Moderately

4

5

2
3
Slightly Moderately

4
5
Seriously Very Seriously

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

4
5
Seriously Very Seriously

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

11. Feeling nervous or afraid
1
Not at all

2
3
Slightly Moderately

12. Worrying about the future and what lies ahead
1
Not at all

2
3
Slightly Moderately

4
5
Seriously Very Seriously

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

4
5
Seriously Very Seriously

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

13. Making a treatment decision
1
Not at all

2
3
Slightly Moderately

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

Seriously Very Seriously

10. Body image and feelings about how you look
1
Not at all

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

Seriously Very Seriously

9. Pain and/or physical discomfort
1

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.
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14. Intimacy, sexual function and/or fertility
1

2

3

Not at all

Slightly Moderately

4

5

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

Seriously Very Seriously

15. Feeling lonely or isolated
1
2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously

16. Health insurance or money worries
1
2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously

17. Problems in your relationship with your spouse/partner
1
2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously

18. Feeling too tired to do the things you need or want to do
1
2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously

19. Managing side effects of treatment (nausea, swelling, etc.)
1
2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously

20. Worrying about family, children and/or friends
1
2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously
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□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

21. Recent weight change (gain or loss)
1
2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously

Today, how concerned are you about...?

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

Please let us know how we
can help you...
(please check all that apply)

(Please circle one option)

22. Exercising and being physically active

1
2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously
23. Tobacco or substance use – by you or someone in your
household
1
2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously

24. Finding reliable information about complementary or
alternative practices
1
2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously

25. Finding meaning and purpose in life
1
2
3
4
5
Not at all Slightly Moderately Seriously Very Seriously
26. What type of cancer do you have?






Blood
Brain and Spine
Breast
Gastrointestinal

 Gynecologic
 Head and Neck
 Liver
 Lung

Pancreatic
 Prostate
 Skin
 Other
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□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

□Have a staff person talk with you.
□Provide you additional information.
□No action needed.

27. Please let us know if you have any additional comments.
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APPENDIX D: DESCRIPTIVE STATISTICS OF ITEMS (N = 317)
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Item Number
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

Mean (M)
3.04
2.17
2.12
2.12
2.31
2.25
2.18
1.61
2.46
2.11
2.28
2.68
2.31
1.59
1.58
2.54
1.29
2.38
2.49
2.16
1.90
2.39
1.27
1.95
1.73
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Standard Deviations (SD)
1.36
1.22
1.29
1.41
1.33
1.29
1.23
1.09
1.27
1.21
1.26
1.30
1.34
1.05
.98
1.40
.81
1.23
1.26
1.26
1.18
1.26
.85
1.23
1.20

APPENDIX E: KMO INDEX AND BARTLETT’S TEST OF SPHERICITY
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Kaiser-Meyer-Olkin Measure
of Sampling Adequacy.
Bartlett’s Test of Sphericity

.93
Approx. Chi-Square
Df.
Sig.
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3620.54
300
0.00

APPENDIX F: SUBSCALE SCORES BY 12 CANCER LOCATIONS
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M(SD)

Distress

Factor Subscale
Treatment
Management
and
Decisions

Breast

2.21
(.96)

2.28
(.90)

2.18
(.92)

1.52
(.92)

1.25
(.84)

Blood

2.09
(.76)

2.14
(.74)

2.16
(.58)

1.25
(.46)

1.11
(.32)

Lung

2.56
(.97)

2.66
(.96)

2.74
(.87)

1.38
(.69)

1.71
(1.38)

Head and Neck

2.23
(.88)

2.27
(.87)

2.20
(.87)

1.55
(.84)

1.27
(.78)

Gynecologic

2.19
(.95)

2.12
(.76)

2.11
(.91)

1.20
(.40)

1.41
(1.08)

Gastrointestinal

2.16
(.69)

2.33
(.77)

2.09
(.75)

1.47
(.72)

1.23
(.83)

Skin

1.67
(.50)

1.73
(.68)

1.94
(.79)

1.04
(.14)

1.00
(0.00)

Prostate

1.88
(.66)

2.08
(1.00)

2.25
(0.96)

1.58
(0.81)

1.31
(0.85)

Liver

1.56
(0.00)

2.00
(0.00)

2.00
(0.00)

1.00
(0.00)

1.00
(0.00)

2.13
(1.06)

2.02
(1.02)

1.90
(1.14)

1.67
(.75)

1.00
(0.00)

2.78
(0.00)

1.75
(0.00)

3.60
(0.00)

1.00
(0.00)

1.00
(0.00)

1.61
(1.15)

1.05
(.23)

Cancer
Location

Brain and
Spine
Pancreatic

Multiple

Lifestyle

Relationship

Substance
Use

2.40
2.28
2.73
(1.00)
(.82)
(1.01)
Note. Standard deviations appear in parentheses below means.
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APPENDIX G: INITIAL COMMUNALITIES
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Item Number
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

Extraction
.46
.54
.73
.51
.43
.58
.76
.52
.64
.48
.75
.73
.63
.67
.58
.37
.67
.59
.68
.54
.53
.67
.50
.52
.49
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